Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sette

Showing results (71-80 of 299) with videos related to

Pageof 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytesK Tahara, K Takesako, A Sette, et al.
Journal of Virology|March 27, 2001
Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51R Thimme, K M Chang, J Pemberton, et al.
Cancer Research|February 2, 1999
Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cellsI Kawashima, V Tsai, S Southwood, et al.
The Journal of Experimental Medicine|April 1, 1995
Altered peptide ligands can control CD4 T lymphocyte differentiation in vivoC Pfeiffer, J Stein, S Southwood, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
Capacity of intact proteins to bind to MHC class II moleculesA Sette, L Adorini, S M Colon, et al.
Science (New York, N.Y.)|March 13, 1987
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptidesS Buus, A Sette, S M Colon, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 6, 2015
Definition of a pool of epitopes that recapitulates the T cell reactivity against major house dust mite allergensD Hinz, C Oseroff, J Pham, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 1997
A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigensL B Nicholson, A Murtaza, B P Hafler, et al.
Vaccine|October 16, 1999
Peptide vaccination using nonionic block copolymers induces protective anti-viral CTL responsesJ G Lanier, M J Newman, E M Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7M P Rudolf, S Man, C J Melief, et al.
Pageof 30

Showing results (71-80 of 299) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytesK Tahara, K Takesako, A Sette, et al.
Journal of Virology|March 27, 2001
Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51R Thimme, K M Chang, J Pemberton, et al.
Cancer Research|February 2, 1999
Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cellsI Kawashima, V Tsai, S Southwood, et al.
The Journal of Experimental Medicine|April 1, 1995
Altered peptide ligands can control CD4 T lymphocyte differentiation in vivoC Pfeiffer, J Stein, S Southwood, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
Capacity of intact proteins to bind to MHC class II moleculesA Sette, L Adorini, S M Colon, et al.
Science (New York, N.Y.)|March 13, 1987
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptidesS Buus, A Sette, S M Colon, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 6, 2015
Definition of a pool of epitopes that recapitulates the T cell reactivity against major house dust mite allergensD Hinz, C Oseroff, J Pham, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 1997
A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigensL B Nicholson, A Murtaza, B P Hafler, et al.
Vaccine|October 16, 1999
Peptide vaccination using nonionic block copolymers induces protective anti-viral CTL responsesJ G Lanier, M J Newman, E M Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7M P Rudolf, S Man, C J Melief, et al.
Pageof 30